Tekla Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-10,100
Closed -$1.54M 145
2016
Q2
$1.54M Buy
+10,100
New +$1.57M 0.06% 140
2015
Q3
Sell
-146,000
Closed -$22.4M 162
2015
Q2
$22.4M Buy
+146,000
New +$23.4M 0.81% 26
2015
Q1
Sell
-285
Closed -$45K 117
2014
Q4
$45K Buy
+285
New +$44.4K ﹤0.01% 95

Other funds holding AMGN

Tekla Capital Management's AMGN Position: Q2 2023 in Review

Tekla Capital Management increased its Amgen (AMGN) stake by 11% in Q2 2023, buying an estimated $14.1M and bringing the position to 616,539 shares worth $137M. The position accounts for 5.36% of the portfolio, ranked #1.

Tekla Capital Management first reported a position in AMGN in Q2 2013 and has held it in 41 quarters since. The position peaked at $155M in Q3 2020. 2,391 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • Tekla Capital Management held 616,539 shares of Amgen worth $137M as of Q2 2023.
  • Tekla Capital Management bought 60,600 Amgen shares in Q2 2023, an estimated $14.1M.
  • Amgen made up 5.36% of Tekla Capital Management's portfolio in Q2 2023, its #1 holding.
  • Tekla Capital Management first reported a position in Amgen in Q2 2013 and has held it in 41 quarters since.
  • Tekla Capital Management's Amgen position peaked at $155M in Q3 2020.
  • 2,391 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.